PB 4 of 2018
National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 1)
National Health Act 1953
I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 22 January 2018
LISA LA RANCE
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
___________________________________________________________________________
Amendment instrument – Pharmaceutical benefits – early supply
1 Name of Instrument
(1) This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 1)
(2) This Instrument may also be cited as PB 4 of 2018.
2 Commencement
This Instrument commences on 1 February 2018.
3 Amendment of PB 120 of 2015
Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).
Schedule 1 Amendments
[1] Schedule 1, omit entry for Cyproheptadine
[2] Schedule 1, after entry for Raloxifene
insert:
Raltegravir | Tablet 600 mg (as potassium) | 20 | 120 | 5 |
|
[3] Schedule 1
omit:
Testosterone | Injection containing testosterone enanthate 250 mg in 1 mL | 20 | 3 | 3 |
|